Category: Drug Discovery
Europe Drug Discovery
-
Europe Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
-
Europe Drug Discovery Market Forecast 2022-2030
... technologies, and increased R&D expenses influence market growth in the region. MARKET INSIGHTS Italy, Russia, France, Germany, the United Kingdom, Spain, Scandinavia, and Rest of Europe are analyzed for the Europe drug discovery market growth ... Read More
-
Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class (Anti-inflammatory, Interferons, NSAIDs and Antihyperglycemics) By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes) By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025 Scope of the Report The report provides an in depth analysis of the global autoimmune disease therapeutics market ... Read More
-
Europe Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in Europe is expected to grow from US$ 1,487.30 million in 2021 to US$ 4,791.46 million by 2028; it ... Read More
-
Europe Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market in Europe is expected to ... Read More
-
Cancer Therapies Market in Europe 2022-2026
... the forecast period. Our report on the cancer therapies market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
Europe Benign Prostatic Hyperplasia Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy (Mono Drug Therapy and Combination Drug Therapy), By Therapeutics Class, By Country and Growth Forecast, 2021 - 2027
... Benign Prostatic Hyperplasia Therapeutics Market would witness market growth of 3.9% CAGR during the forecast period (2021-2027). BPH is neither a malignancy nor a cause of prostate cancer. BPH, on the other hand, can be ... Read More
-
Blood Based Biomarker Market, By Type (Screening Biomarker, Diagnosis Biomarker, and Others), By Disease (Cancer, Neurological Disorders, and Others), By Application (Diagnostics, Drug Discovery, and Personalized Medicine), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The term biomarker, or biological marker, refers to a broad range of measures that capture what is happening in a ... Read More
-
Chronic Liver Diseases Therapeutics Market, by Treatment Type (Antiviral Drugs, Immunosuppressant’s, Vaccines, Immunoglobulin’s, Corticosteroids, Targeted Therapy, and Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The liver ... Read More
-
Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis Optica and Paroxysmal Nocturnal Hemoglobinuria), Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Oral and Subcutaneous), Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035
... Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route ... Read More
-
Antiviral Drugs Market, by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors and Others), by Type (Branded and Generics), by Application (HIV, Hepatitis, Herpes, Influenza, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Antiviral drugs are prescription ... Read More
-
Europe Aptamers Market By Type (DNA Aptamers, XNA Aptamers and RNA Aptamers), By Application (Therapeutics Development, Research & Development, Diagnostic and Others), By Technology (SELEX and Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs and Others), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
... & Government Research Institutes, CROs and Others), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 The Europe Aptamers Market would witness market growth of 17.1% CAGR during the forecast period (2021-2027). Aptamers appear ... Read More
-
Non-alcoholic Steatohepatitis Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, II, III, IV), By Study Design (Interventional, Expanded Access), By Region (APAC, Europe), And Segment Forecasts, 2022 - 2030
... to a new report by Grand View Research, Inc. Rising healthcare expenditure, cases of obesity, and prevalence of non-alcoholic steatohepatitis (NASH) are the factors driving the growth of this market. Due to the COVID-19 pandemic, ... Read More
-
Global Pneumonia Therapeutics Market; By Therapeutics (Prevention Vaccine, Treatment Drugs and Oxygen Therapy), By Drug Class (Antibacterial Drugs (Macrolide, Quinolones, and Others), Antiviral Drugs and Antifungal Drugs), By Age Group (Paediatric, Adult and Geriatric), By Infection Type (Hospital-acquired Pneumonia [HAP], Community-acquired Pneumonia [CAP] and Ventilator-associated Pneumonia [VAP]), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, the Asia-Pacific, the Middle-East & Africa, and Latin America)Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Infection Type (Hospital-acquired Pneumonia [HAP], Community-acquired Pneumonia [CAP] and Ventilator-associated Pneumonia [VAP]), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, the Asia-Pacific, the Middle-East & Africa, and Latin ... Read More
Research Assistance
